Updates on Device-Based Therapies for Patients with Heart Failure

Area of Science:

• Cardiology and Cardiovascular Devices
• Heart Failure Management

Background:

• Heart failure represents a significant and growing global health challenge.
• While optimal medical therapy is foundational, device-based interventions offer substantial benefits in reducing patient morbidity and mortality.

Purpose of the Study:

• To review major device-related clinical trials published in 2017 concerning heart failure management.
• To explore the impact of device therapies on heart failure outcomes and identify areas for future research.

Main Methods:

• Review of pivotal device-related clinical trials from 2017.
• Focus on trials involving implantable cardioverter-defibrillators, hemodynamic monitoring, remote monitoring systems, autonomic nervous system modulation, ventricular assist devices, and device-based management of valvular heart disease.

Main Results:

• Significant advancements were observed across various device categories in 2017.
• These trials contribute to a better understanding of device efficacy in managing heart failure patients.

Conclusions:

• Device-based therapies are integral to modern heart failure management, complementing medical treatments.
• Continued research and clinical trials are essential to fully elucidate the long-term mortality and morbidity benefits, as well as cost-effectiveness, of these advanced therapies.